Stock MSCL SATELLOS BIOSCIENCE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Satellos Bioscience Inc.

Equities

MSCL

CA80401L3083

Market Closed - Toronto S.E.
Other stock markets
 03:59:59 2024-06-06 pm EDT 		5-day change 1st Jan Change
0.57 CAD +9.62% Intraday chart for Satellos Bioscience Inc. +16.33% +32.56%
May. 28 Satellos Bioscience Forms Advisory Board to Advance SAT-3247 in Duchenne Muscular Dystrophy Treatment MT
May. 28 Satellos Bioscience Inc. Brief: Announcing Formation of Clinical Advisory Board to Support Advancing SAT-3247 in Clinical Trial Development for Duchenne Muscular Dystrophy MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
SATELLOS BIOSCIENCE INC.
Bio Therapeutic Drugs
+9.62%+16.33%+32.56%-1.72% - 42.78M
Bullish
Neutral
Neutral
  1. Stock Market
  2. Equities
  3. MSCL Stock
  4. Charts Satellos Bioscience Inc.
  5. Relative Strength Chart